Aurora Spine Corporation (TSXV: ASG | OTCQB: ASAPF) Q1 2025 Earnings | May 22, 2025

About this video

Aurora Spine Corporation (TSXV: ASG | OTCQB: ASAPF), a leader in minimally invasive spinal implant technologies, reported record Q1 2025 financial results on May 22, 2025. Revenue for the quarter reached $4.42 million, up 10% year-over-year, driven by a 33.8% surge in SiLO-TFX sales and strong demand for the company’s innovative DEXA Technology™ platform and newly FDA-cleared AERO™ Facet Fusion System. The DEXA-L lumbar implant, another recent FDA-cleared product, is positioned to address a $2.3 billion market segment by reducing implant subsidence risks. Despite the revenue growth, Aurora Spine posted a net loss of $350,000, compared to a $267,000 loss a year ago, as gross margins dipped to 58% from 61.9% due to higher distributor commissions and shipping costs. The company continues to invest in sales force expansion and geographic market development, aiming for 20% annual revenue growth and profitability. Cash position at quarter-end was $488,000, with flexibility to raise additional capital if needed. Aurora Spine closed patient data collection for its REFINE study on the ZIP™ Interspinous Fixation device, with results to be presented at the ASPN conference in July 2025, underscoring its commitment to clinical validation and evidence-based innovation. Management highlighted the company’s strategic focus on launching new products, expanding its sales team, and leveraging FDA clearances to capture a larger share of the $15 billion global spinal implant market. Outlook: Continued rollout of AERO™ Facet Fusion System and DEXA-L lumbar implant Focus on clinical data publication and adoption in ambulatory spine procedures Targeting 20% annual revenue growth and improved profitability Strategic expansion into new geographic markets and sales channels About Inside Ticker: For more expert analysis and real-time updates on Aurora Spine Corporation (TSXV: ASG | OTCQB: ASAPF) and other market movers, follow Inside Ticker and visit InsideTicker.com for in-depth reports, financial insights, and the latest news on leading companies. #AuroraSpine #ASG #ASAPF #Q12025 #Earnings #SpineSurgery #MedicalDevices #FinancialResults #FDA #Innovation #InsideTicker